Bionano genomics reports preliminary fourth quarter and full-year 2022 results

- preliminary q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over q4 2021- reached installed base of 240 systems as of ye 2022; 46% increase over ye 2021- achieved or exceeded all stated goals and milestones for the full year 2022
BNGO Ratings Summary
BNGO Quant Ranking